Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trabecular Meshwork | 3 | 2022 | 74 | 1.110 |
Why?
|
| Intellectual Disability | 6 | 2023 | 178 | 0.940 |
Why?
|
| Neurodevelopmental Disorders | 6 | 2024 | 226 | 0.840 |
Why?
|
| Chondroitin Sulfates | 2 | 2020 | 35 | 0.750 |
Why?
|
| Collagen | 3 | 2020 | 455 | 0.740 |
Why?
|
| Pulp Capping and Pulpectomy Agents | 1 | 2021 | 1 | 0.690 |
Why?
|
| Glycosaminoglycans | 2 | 2022 | 79 | 0.670 |
Why?
|
| Chitosan | 1 | 2021 | 39 | 0.660 |
Why?
|
| Tissue Scaffolds | 2 | 2020 | 221 | 0.640 |
Why?
|
| Fibronectins | 1 | 2020 | 136 | 0.610 |
Why?
|
| Biocompatible Materials | 2 | 2020 | 429 | 0.570 |
Why?
|
| Osteogenesis | 2 | 2021 | 204 | 0.260 |
Why?
|
| Glaucoma | 2 | 2022 | 250 | 0.240 |
Why?
|
| Nanoparticles | 2 | 2022 | 516 | 0.210 |
Why?
|
| Ataxia | 1 | 2024 | 69 | 0.210 |
Why?
|
| RNA Polymerase III | 1 | 2024 | 34 | 0.210 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2024 | 59 | 0.200 |
Why?
|
| Cerium | 2 | 2022 | 14 | 0.200 |
Why?
|
| Megalencephaly | 1 | 2023 | 20 | 0.200 |
Why?
|
| Spliceosomes | 1 | 2024 | 54 | 0.200 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2022 | 55 | 0.190 |
Why?
|
| Movement Disorders | 1 | 2023 | 69 | 0.190 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 12 | 0.180 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 46 | 0.180 |
Why?
|
| Apyrase | 1 | 2022 | 27 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2023 | 155 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2023 | 147 | 0.180 |
Why?
|
| Dental Pulp Capping | 1 | 2021 | 1 | 0.170 |
Why?
|
| Calcium Phosphates | 1 | 2021 | 28 | 0.170 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2021 | 6 | 0.170 |
Why?
|
| Wound Healing | 2 | 2022 | 354 | 0.160 |
Why?
|
| Phenotype | 6 | 2024 | 3138 | 0.160 |
Why?
|
| Microcephaly | 1 | 2021 | 104 | 0.160 |
Why?
|
| White Matter | 1 | 2022 | 152 | 0.160 |
Why?
|
| Cryogels | 1 | 2019 | 3 | 0.150 |
Why?
|
| Porosity | 2 | 2017 | 94 | 0.150 |
Why?
|
| Thrombosis | 1 | 2024 | 401 | 0.150 |
Why?
|
| Extracellular Matrix | 2 | 2022 | 561 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 199 | 0.140 |
Why?
|
| Receptors, AMPA | 1 | 2019 | 147 | 0.130 |
Why?
|
| Apatites | 1 | 2017 | 4 | 0.130 |
Why?
|
| Diabetic Angiopathies | 1 | 2019 | 264 | 0.130 |
Why?
|
| Microscopy | 1 | 2019 | 147 | 0.130 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2017 | 65 | 0.130 |
Why?
|
| Mutation, Missense | 3 | 2024 | 335 | 0.120 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2017 | 80 | 0.120 |
Why?
|
| Biomimetic Materials | 1 | 2016 | 78 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 582 | 0.110 |
Why?
|
| Stroke | 1 | 2024 | 1270 | 0.110 |
Why?
|
| Swine | 1 | 2016 | 822 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 372 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 686 | 0.100 |
Why?
|
| Mutation | 2 | 2022 | 4071 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1092 | 0.100 |
Why?
|
| Humans | 15 | 2024 | 145140 | 0.090 |
Why?
|
| Pedigree | 2 | 2022 | 515 | 0.080 |
Why?
|
| Animals | 6 | 2024 | 37952 | 0.070 |
Why?
|
| Zebrafish | 2 | 2024 | 532 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 738 | 0.070 |
Why?
|
| Seizures | 2 | 2023 | 482 | 0.070 |
Why?
|
| Plasminogen | 1 | 2024 | 27 | 0.050 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2023 | 10 | 0.050 |
Why?
|
| DNA Repair Enzymes | 1 | 2024 | 29 | 0.050 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2023 | 9 | 0.050 |
Why?
|
| RNA Splicing Factors | 1 | 2024 | 66 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2023 | 80 | 0.050 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2023 | 76 | 0.050 |
Why?
|
| Histone Demethylases | 1 | 2022 | 38 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 164 | 0.050 |
Why?
|
| Laminin | 1 | 2022 | 72 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 10 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 51 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2023 | 159 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 284 | 0.050 |
Why?
|
| Syndrome | 1 | 2023 | 380 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2024 | 284 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2024 | 246 | 0.040 |
Why?
|
| Paraplegia | 1 | 2022 | 60 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2024 | 248 | 0.040 |
Why?
|
| Cadherin Related Proteins | 1 | 2021 | 12 | 0.040 |
Why?
|
| Face | 1 | 2022 | 174 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2023 | 212 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 317 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2023 | 236 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 54 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 554 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2023 | 740 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2023 | 281 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 456 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 326 | 0.040 |
Why?
|
| Mice | 3 | 2023 | 18303 | 0.040 |
Why?
|
| Cadherins | 1 | 2021 | 200 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 45 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 311 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 367 | 0.040 |
Why?
|
| Alginates | 1 | 2019 | 60 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 187 | 0.040 |
Why?
|
| Lasers | 1 | 2019 | 126 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 312 | 0.030 |
Why?
|
| Child | 3 | 2024 | 22670 | 0.030 |
Why?
|
| Gene Expression | 1 | 2023 | 1474 | 0.030 |
Why?
|
| Infant | 2 | 2024 | 10060 | 0.030 |
Why?
|
| Particle Size | 1 | 2019 | 381 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 408 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2017 | 76 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2024 | 11835 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 553 | 0.030 |
Why?
|
| Female | 5 | 2024 | 78636 | 0.030 |
Why?
|
| Proteomics | 1 | 2023 | 1185 | 0.030 |
Why?
|
| Light | 1 | 2019 | 403 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 1597 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2857 | 0.030 |
Why?
|
| Hydrogels | 1 | 2022 | 701 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 2235 | 0.030 |
Why?
|
| Male | 4 | 2024 | 72664 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 1454 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 2588 | 0.020 |
Why?
|
| Inflammation | 1 | 2022 | 2876 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5988 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 2934 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3892 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 14176 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 22479 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 40665 | 0.010 |
Why?
|